MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players

NEW YORK, May 27, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players
http://www.reportlinker.com/p01190437/MediPoint-Peripheral-Vascular-Stents-for-the-Lower-Extremity---Current-and-Future-Players.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment

MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players

Summary

GlobalData has released its medical devices report, "MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players". The report is an essential source of information and analysis on the global Peripheral Vascular Stent (PVS) market. Through GlobalData's analysis, it is evident that currently the peripheral vascular stent market for the lower extremity is saturated with bare metal stents, followed by covered stents. However, as clinical data and appropriate reimbursement and costs are established, adoption of innovative stent technologies such as drug-eluting stents and bioabsorbable stents will increase in the future. Key players in the peripheral vascular stents market include Abbott Vascular, Bard Peripheral Vascular, Biotronik, Boston Scientific, Cook Medical, Cordis Corporation, Covidien, Medtronic and W.L. Gore and Associates. with emerging players including Atrium Medical Corporation, IDEV Technologies, and Terumo Corporation.

Scope

- Investigation of current and future market competition for Peripheral Vascular Stent (PVS) market.
- Competitor assessment.
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL), including interventionists

Reasons to buy

- Gain a high level view of the trends shaping and driving the Peripheral Vascular Stent (PVS) market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Table of Contents

1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 12
2 Introduction 13
2.1 Catalyst 14
3 Competitive Assessment 15
3.1 Overview 15
3.1.1 Peripheral Vascular Stent Market 15
3.2 Products 18
3.2.1 Bare Metal Stents 18
3.2.2 Drug-Eluting Stents 102
3.2.3 Covered Stents 109
3.2.4 Bioabsorbable Stents 119
4 Pipeline Products 122
4.1 Overview 122
4.2 Pipeline by Phase of Development 123
4.3 Pipeline Product Profiles – Peripheral Artery Disease 125
4.3.1 Citation Stent 125
4.3.2 MR-Enhanced Stents 126
4.3.3 ArtiStent 127
4.3.4 Hybrid Dynamic Stent 127
4.3.5 Nipro Corporation Peripheral Stent 127
4.3.6 Yukon 128
4.3.7 iCAST 130
4.3.8 Peritoneal-Lined Stents 132
4.3.9 LifeJacket Stent Graft 133
4.3.10 Esprit Bioabsorbable Vascular Scaffold (BVS) 133
4.3.11 Magic Explorer Stent 135
4.3.12 Stanza 137
4.3.13 3D Biotek Bioresorbable Stent 139
4.3.14 Archer Stent 140
4.3.15 ART Stent 141
4.3.16 Amaranth Bioabsorbable Scaffold 141
4.3.17 TephaFLEX Absorbable Peripheral Stent 141
4.3.18 Zorion Medical Stent 142
4.3.19 Summary 142
5 Current and Future Players 143
5.1 Overview 143
5.2 Trends in Corporate Strategy 144
5.3 Company Profiles 147
5.3.1 Abbott Vascular 147
5.3.2 Amaranth Medical 149
5.3.3 Arterial Remodeling Technologies 151
5.3.4 Atrium Medical Corporation 153
5.3.5 Bard Peripheral Vascular (C.R. Bard) 155
5.3.6 Biotronik 157
5.3.7 Boston Scientific Corporation 159
5.3.8 3D Biotek 161
5.3.9 480 Biomedical 163
5.3.10 Cook Medical 165
5.3.11 Cordis Corporation (Johnson & Johnson) 167
5.3.12 CorInnova 169
5.3.13 Covidien 171
5.3.14 Cytograft Tissue Engineering 173
5.3.15 Flexible Stenting Solutions 175
5.3.16 IDEV Technologies 177
5.3.17 Kyoto Medical Planning 179
5.3.18 Medtronic 182
5.3.19 Nexeon Stent 185
5.3.20 Nipro Corporation 187
5.3.21 NovoStent Corporation 189
5.3.22 OptiMed 191
5.3.23 PeriTec Biosciences 193
5.3.24 Synergy Flow 195
5.3.25 Tepha 197
5.3.26 Terumo Corporation 199
5.3.27 TissueGen 201
5.3.28 Translumina 203
5.3.29 Vascular Concepts 205
5.3.30 Veryan Medical 207
5.3.31 VueKlar Cardiovascular 209
5.3.32 W.L. Gore & Associates 211
5.3.33 Zorion Medical 213
6 Appendix 215
6.1 Bibliography 215
6.2 Abbreviations 238
6.3 Report Methodology 241
6.3.1 Overview 241
6.3.2 Coverage 241
6.3.3 Secondary Research 241
6.3.4 Forecasting Methodology 242
6.4 Physicians and Specialists Included in this Study 243
6.5 Physician Survey 245
6.6 About the Authors 245
6.6.1 Analysts 245
6.6.2 Global Head of Healthcare 246
6.7 About MediPoint 247
6.8 About GlobalData 247
6.9 Contact Us 247
6.10 Disclaimer 247

List of Tables

Table 1: Global Peripheral Vascular Stent Market ($m) for Each Type of Artery in the Lower Extremity, 2012 16
Table 2: Marketed Bare Metal Stent Products - Self-Expanding Stents 18
Table 3: Marketed Bare Metal Stent Products - Balloon-Expanding Stents 19
Table 4: Absolute Stent Family Product Portfolio 20
Table 5: Absolute Stent SWOT Analysis, 2013 23
Table 6: Astron Stent Product Portfolio 25
Table 7: Astron Stent SWOT Analysis, 2013 26
Table 8: BioMimics 3D Stent Product Portfolio 27
Table 9: BioMimics 3D Stent SWOT Analysis, 2013 28
Table 10: Complete Stent SE Product Portfolio 29
Table 11: Complete SE Stent SWOT Analysis, 2013 32
Table 12: E-Luminexx Stent Product Portfolio 33
Table 13: E-Luminexx Stent SWOT Analysis, 2013 34
Table 14: Epic Stent Product Portfolio 35
Table 15: Epic Stent SWOT Analysis, 2013 37
Table 16: FlexStent Iliac Stent System Product Portfolio 38
Table 17: FlexStent Iliac Stent System SWOT Analysis, 2013 39
Table 18: LifeStent Vascular Stent System Product Portfolio 40
Table 19: LifeStent Vascular Stent System SWOT Analysis, 2013 43
Table 20: Maris Deep Stent Product Portfolio 44
Table 21: Maris Deep Stent SWOT Analysis, 2013 45
Table 22: Maris Plus Stent Product Portfolio 46
Table 23: Maris Plus Stent SWOT Analysis, 2013 47
Table 24: Misago Stent Product Portfolio 48
Table 25: Misago Stent SWOT Analysis, 2013 50
Table 26: NovoStent Samba Stent System Product Portfolio 51
Table 27: NovoStent Samba Stent System SWOT Analysis, 2013 53
Table 28: Protégé Family of Stents Product Portfolio 54
Table 29: Protégé Family of Stents SWOT Analysis, 2013 56
Table 30: Pulsar 18 Stent Product Portfolio 57
Table 31: Pulsar 18 Stent SWOT Analysis, 2013 58
Table 32: SMART Stent Product Portfolio 59
Table 33: SMART Stent SWOT Analysis, 2013 61
Table 34: Sinus Stent Family Product Portfolio 62
Table 35: Sinus Stent Family SWOT Analysis, 2013 64
Table 36: Supera Veritas Stent Product Portfolio 65
Table 37: Supera Veritas Stent SWOT Analysis, 2013 67
Table 38: Wallstent Product Portfolio 68
Table 39: Wallstent SWOT Analysis, 2013 69
Table 40: Xpert Stent Product Portfolio 70
Table 41: Xpert Stent SWOT Analysis, 2013 73
Table 42: Zilver Stent Product Portfolio 74
Table 43: Zilver Stent SWOT Analysis, 2013 77
Table 44: Assurant Cobalt Stent Product Portfolio 78
Table 45: Assurant Cobalt Stent SWOT Analysis, 2013 80
Table 46: Chromis Deep Stent Product Portfolio 81
Table 47: Chromis Deep Stent SWOT Analysis, 2013 83
Table 48: Dynamic Stent Product Portfolio 84
Table 49: Dynamic Stent SWOT Analysis, 2013 85
Table 50: Express LD Product Portfolio 86
Table 51: Express LD SWOT Analysis, 2013 88
Table 52: IntraStent LD Stent Product Portfolio 89
Table 53: IntraStent LD Stent SWOT Analysis, 2013 90
Table 54: Omnilink Elite Stent Product Portfolio 91
Table 55: Omnilink Elite Stent SWOT Analysis, 2013 93
Table 56: ParaMount Mini GPS Product Portfolio 94
Table 57: ParaMount Mini GPS SWOT Analysis, 2013 95
Table 58: ProStar Stent Product Portfolio 96
Table 59: ProStar Stent SWOT Analysis, 2013 97
Table 60: Scuba Stent Product Portfolio 98
Table 61: Scuba Stent SWOT Analysis, 2013 99
Table 62: Visi-Pro Stent Product Portfolio 100
Table 63: Visi-Pro Stent SWOT Analysis, 2013 101
Table 64: Marketed Drug-Eluting Stent Products 102
Table 65: Xience Prime BTK Stent Product Portfolio 102
Table 66: Xience Prime BTK Stent SWOT Analysis, 2013 104
Table 67: Zilver PTX Stent Product Portfolio 105
Table 68: Zilver PTX Stent SWOT Analysis, 2013 108
Table 69: Marketed Covered Stent Products 109
Table 70: Gore Viabahn Stent Product Portfolio 110
Table 71: Gore Viabahn Stent SWOT Analysis, 2013 113
Table 72: Gore Tigris Stent Product Portfolio 114
Table 73: Gore Tigris Stent SWOT Analysis, 2013 115
Table 74: V12 Covered Stents Product Portfolio 116
Table 75: V12 Covered Stents SWOT Analysis, 2013 118
Table 76: Remedy Stent Product Portfolio 119
Table 77: Remedy Stent SWOT Analysis, 2012 121
Table 78: Global Peripheral Vascular Stent Product Pipeline 124
Table 79: Citation Stent SWOT Analysis, 2013 125
Table 80: MR-Enhanced Stents SWOT Analysis, 2013 126
Table 81: Yukon Stent SWOT Analysis, 2013 129
Table 82: iCAST Stent SWOT Analysis, 2013 131
Table 83: Peritoneal-Lined Stents SWOT Analysis, 2013 132
Table 84: Esprit BVS SWOT Analysis, 2013 134
Table 85: Magic Explorer Stent SWOT Analysis, 2013 136
Table 86: Stanza Stent SWOT Analysis, 2013 138
Table 87: 3D Biotek Bioresorbable Stent SWOT Analysis, 2013 139
Table 88: Archer Stent SWOT Analysis, 2013 140
Table 89: Abbott Vascular Company Profile 147
Table 90: Abbott Vascular, Marketed and Pipeline Vascular Stent Products 148
Table 91: Abbott Vascular SWOT Analysis, 2013 148
Table 92: Amaranth Medical Company Profile 149
Table 93: Amaranth Medical, Pipeline Vascular Stent Products 150
Table 94: Amaranth Medical SWOT Analysis, 2013 150
Table 95: Arterial Remodeling Technologies Company Profile 151
Table 96: Arterial Remodeling Technologies' Pipeline Vascular Stent Products 152
Table 97: Arterial Remodeling Technologies SWOT Analysis, 2013 152
Table 98: Atrium Medical Corporation Company Profile 153
Table 99: Atrium Medical Corporation, Marketed and Pipeline Vascular Stent Products 154
Table 100: Atrium Medical Corporation SWOT Analysis, 2013 154
Table 101: Bard Peripheral Vascular (C.R. Bard) Company Profile 155
Table 102: Bard Peripheral Vascular (C.R. Bard), Marketed Stent Products 156
Table 103: Bard Peripheral Vascular (C.R. Bard) SWOT Analysis, 2013 156
Table 104: Biotronik Company Profile 157
Table 105: Marketed and Pipeline Vascular Stent Products by Biotronik 158
Table 106: Biotronik SWOT Analysis, 2013 158
Table 107: Boston Scientific Corporation Company Profile 159
Table 108: Boston Scientific Corporation, Marketed and Pipeline Vascular Stent Products 160
Table 109: Boston Scientific Corporation SWOT Analysis, 2013 160
Table 110: Company Profile – 3D Biotek 161
Table 111: 3D Biotek's Pipeline Vascular Stent Products 162
Table 112: 3D Biotek SWOT Analysis, 2013 162
Table 113: 480 Biomedical Company Profile 163
Table 114: 480 Biomedical, Pipeline Vascular Stent Products 164
Table 115: 480 Biomedical SWOT Analysis, 2013 164
Table 116: Cook Medical Company Profile 165
Table 117: Cook Medical, Marketed Vascular Stent Products 166
Table 118: Cook Medical SWOT Analysis, 2013 166
Table 119: Cordis Corporation Company Profile 167
Table 120: Cordis Corporation's Marketed Vascular Stent Products 168
Table 121: Cordis Corporation SWOT Analysis, 2013 168
Table 122: CorInnova Company Profile 169
Table 123: CorInnova, Pipeline Vascular Stent Products 169
Table 124: CorInnova SWOT Analysis, 2013 170
Table 125: Covidien Company Profile 171
Table 126: Covidien's Marketed Vascular Stent Products 172
Table 127: Covidien SWOT Analysis, 2013 172
Table 128: Company Profile – Cytograft Tissue Engineering 173
Table 129: Cytograft Tissue Engineering, Pipeline Vascular Stent Products 174
Table 130: Cytograft Tissue Engineering SWOT Analysis, 2013 174
Table 131: Flexible Stenting Solutions Company Profile 175
Table 132: Flexible Stenting Solutions' Marketed Vascular Stent Products 176
Table 133: Flexible Stenting Solutions SWOT Analysis, 2013 176
Table 134: IDEV Technologies Company Profile 177
Table 135: IDEV Technologies' Marketed Vascular Stent Products 178
Table 136: IDEV Technologies SWOT Analysis, 2013 178
Table 137: Kyoto Medical Planning Company Profile 179
Table 138: Kyoto Medical Planning's Marketed Vascular Stent Product 181
Table 139: Kyoto Medical Planning SWOT Analysis, 2013 181
Table 140: Medtronic Company Profile 182
Table 141: Medtronic's Marketed Vascular Stent Products 183
Table 142: Medtronic SWOT Analysis, 2013 184
Table 143: Nexeon Stent Company Profile 185
Table 144: Nexeon Stent's Pipeline Vascular Stent Product 186
Table 145: Nexeon Stent SWOT Analysis, 2013 186
Table 146: Nipro Corporation Company Profile 187
Table 147: Nipro Corporation's Pipeline Vascular Stent Product 187
Table 148: Nipro Corporation SWOT Analysis, 2013 188
Table 149: NovoStent Corporation Company Profile 189
Table 150: NovoStent Corporation's Marketed Vascular Stent Product 190
Table 151: NovoStent Corporation SWOT Analysis, 2013 190
Table 152: OptiMed Company Profile 191
Table 153: OptiMed's Marketed Vascular Stent Products 192
Table 154: OptiMed SWOT Analysis, 2013 192
Table 155: Company Profile – PeriTec Biosciences 193
Table 156: PeriTec Bioscience's Pipeline Vascular Stent Product 194
Table 157: PeriTec Biosciences SWOT Analysis, 2013 194
Table 158: Synergy Flow Company Profile 195
Table 159: Pipeline Vascular Stent Product by Synergy Flow 195
Table 160: Synergy Flow SWOT Analysis, 2013 196
Table 161: Tepha Company Profile 197
Table 162: Tepha Medical Device's Pipeline Vascular Stent Product 198
Table 163: Tepha SWOT Analysis, 2013 198
Table 164: Terumo Corporation Company Profile 199
Table 165: Terumo Corporation's Marketed Vascular Stent Products 200
Table 166: Terumo Corporation SWOT Analysis, 2013 200
Table 167: TissueGen Company Profile 201
Table 168: TissueGen's Pipeline Vascular Stent Product 201
Table 169: TissueGen SWOT Analysis, 2013 202
Table 170: Translumina Company Profile 203
Table 171: Translumina's Pipeline Vascular Stent Product 204
Table 172: Translumina SWOT Analysis, 2013 204
Table 173: Vascular Concepts Company Profile 205
Table 174: Marketed Vascular Stent Products by Vascular Concepts 205
Table 175: Vascular Concepts SWOT Analysis, 2013 206
Table 176: Company Profile – Veryan Medical 207
Table 177: Marketed Vascular Stent Products by Veryan Medical 208
Table 178: Veryan Medical SWOT Analysis, 2013 208
Table 179: VueKlar Cardiovascular Company Profile 209
Table 180: VueKlar Cardiovascular's Pipeline Vascular Stent Product 210
Table 181: VueKlar Cardiovascular SWOT Analysis, 2013 210
Table 182: W.L. Gore & Associates Company Profile 211
Table 183: W.L. Gore & Associates' Marketed Vascular Stent Products 212
Table 184: W.L. Gore & Associates SWOT Analysis, 2013 212
Table 185: Zorion Medical Company Profile 213
Table 186: Pipeline Vascular Stent Products by Zorion Medical 213
Table 187: Zorion Medical SWOT Analysis, 2013 214
Table 188: Physicians Surveyed, By Country 245

List of Figures

Figure 1: Global Peripheral Vascular Stent Market for Treating Peripheral Artery Disease in the Lower Extremity ($), 2012 15
Figure 2: Global Peripheral Vascular Stent Market ($m) for Each Type of Artery, 2012 17
Figure 3: Remedy Stent for Treating Peripheral Artery Disease 120
Figure 4: Pipeline Peripheral Vascular Stent Products, 2013 122
Figure 5: Global Peripheral Vascular Stent Pipeline by Stage of Clinical Development, 2013 123
Figure 6: Global Peripheral Vascular Stent Market for Treating Peripheral Artery Disease in the Lower Extremity, Company Share (%), 2012 143
Figure 7: Global Peripheral Vascular Stent Market for Each Type of Artery, Company Share (%), 2012 145
Figure 8: Kyoto Medical Planning, Sales Volume ($m), May 2002–May 2012 180

Companies Mentioned
Abbott Vascular
Amaranth Medical
Arterial Remodeling Technologies
Atrium Medical Corporation
Bard Peripheral Vascular (C.R. Bard)
Biotronik
Boston Scientific Corporation
3D Biotek
480 Biomedical
Cook Medical
Cordis Corporation (Johnson & Johnson

To order this report:
Surgical_Equipment Industry: MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players

__________________________
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker